Literature DB >> 11494277

Painful sensory polyneuropathy associated with impaired glucose tolerance.

J R Singleton1, A G Smith, M B Bromberg.   

Abstract

We examined records of 121 patients coded as idiopathic polyneuropathy, extracting neuropathy symptoms, electromyographic data, and diagnostic blood work. Of 89 patients screened for glucose handling, 28 demonstrated frank diabetes mellitus. Of the remaining 61 patients, 15 (25%) had impaired glucose tolerance (IGT) by American Diabetes Association criteria (serum glucose 140--200 mg/dl 2 h after a 75-g glucose load). Excluding those with diabetes mellitus, 35% of patients with neuropathic pain had IGT, more than twice the prevalence found in large, unselected population studies. No other common etiology of polyneuropathy was identified. Two-hour oral glucose tolerance test results were often abnormal, whereas fasting glucose or hemoglobin A1c was normal. Bias due to referral pattern, body weight, or genetics might affect the comparison of our polyneuropathy cohort with a broader, population-based control. However, our results corroborate an association between IGT and painful sensory polyneuropathy and link these patients syndromically to the typical painful polyneuropathy of diabetes mellitus. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11494277     DOI: 10.1002/mus.1136

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  51 in total

1.  Thermal threshold: research study on small fiber dysfunction in distal diabetic polyneuropathy.

Authors:  Pedro Jimenez-Cohl; Carlos Grekin; Cristian Leyton; Claudio Vargas; Roberto Villaseca
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

2.  Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.

Authors:  Lawrence Coppey; Eric Davidson; Bao Lu; Craig Gerard; Mark Yorek
Journal:  Neuropharmacology       Date:  2010-09-16       Impact factor: 5.250

3.  Diabetes and its chronic complications in the She ethnic minority group of China.

Authors:  Yinghua Lin; Yuan Xu; Gang Chen; Xiaolan Lai; Baoying Huang; Zichun Chen; Longteng Yao; Shaoheng Zhu; Jin Yao; Junping Wen; Huibin Huang; Caijing Lin
Journal:  Diabetes Technol Ther       Date:  2012-02-03       Impact factor: 6.118

4.  Diet-induced obesity in Sprague-Dawley rats causes microvascular and neural dysfunction.

Authors:  Eric P Davidson; Lawrence J Coppey; Nigel A Calcutt; Christine L Oltman; Mark A Yorek
Journal:  Diabetes Metab Res Rev       Date:  2010-05       Impact factor: 4.876

Review 5.  Early diabetic neuropathy: triggers and mechanisms.

Authors:  Maxim Dobretsov; Dmitry Romanovsky; Joseph R Stimers
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

Review 6.  Diagnosis and treatment of pain in small-fiber neuropathy.

Authors:  Alexandra Hovaguimian; Christopher H Gibbons
Journal:  Curr Pain Headache Rep       Date:  2011-06

7.  The meaning of distal sensory loss and absent ankle reflexes in relation to age: a meta-analysis.

Authors:  Alexander F J E Vrancken; Sandra Kalmijn; Frans Brugman; Gabriël J E Rinkel; Nicolette C Notermans
Journal:  J Neurol       Date:  2005-11-23       Impact factor: 4.849

Review 8.  Neuropathy in prediabetes: does the clock start ticking early?

Authors:  Nikolaos Papanas; Aaron I Vinik; Dan Ziegler
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

9.  Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation.

Authors:  Amanda Peltier; A Gordon Smith; James W Russell; Kiran Sheikh; Billie Bixby; James Howard; Jonathan Goldstein; Yanna Song; Lily Wang; Eva L Feldman; J Robinson Singleton
Journal:  Muscle Nerve       Date:  2009-04       Impact factor: 3.217

10.  Does prediabetes cause small fiber sensory polyneuropathy? Does it matter?

Authors:  C D Kassardjian; P J B Dyck; J L Davies; Rickey E Carter; P J Dyck
Journal:  J Neurol Sci       Date:  2015-05-27       Impact factor: 3.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.